Today's News | Note: News feeds may no longer be available for the articles on this page.

Pfizer pancreatic cancer drug fails, trial halted 10:53 AM 1/30/2009
Reuters - USA
NEW YORK (Reuters) - Pfizer Inc, in its latest research setback, said on Friday it stopped a late stage study of an experimental drug to treat advanced ...

BioMS drug fails mid-stage study, stock off 50 pct 2:04 PM 1/30/2009
Reuters - USA
BioMS Medical Corp's lead drug dirucotide for the treatment of multiple sclerosis failed in a mid-stage study. Dirucotide did not meet primary nor secondary endpoints. ...

Roche lowers offer for Genentech to $42.5 billion 5:23 AM 1/30/2009
MarketWatch - USA
Roche Holdings cut its offer for Genentech taking the matter to shareholders after the biotech refused previous buyout offers from its majority owner. ...

Indian Stocks Decline - Sun Pharmaceutical Drops 4:43 AM 1/30/2009
Bloomberg - USA
Sun Pharmaceutical Industries Ltd's US unit Caraco Pharmaceutical Laboratories Inc reported a 32 percent drop in sales and cut its revenue forecast for fiscal 2009. ...

Lilly Looks Beyond Loss To Prasugrel 2:03 AM 1/30/2009
Forbes - NY,USA
A US FDA advisory panel is set to discuss Lilly's blood thinner prasugrel on February 3. The drug is expected to be a blockbuster with sales over $1 billion. ...

Lilly profit falls on ImClone charges 8:46 AM 1/29/2009
Reuters - USA
Charges from the ImClone deal hit $4.73 billion while sales of schizophrenia drug Zyprexa were off 10 percent. ...

Another trial is likely for Pro-Pharmaceuticals drug 7:22 AM 1/29/2009
Boston Globe - United States
Pro-Pharmaceuticals Inc said the US FDA will require a Phase III trial for DAVANAT to demonstrate superiority to the best standard of care for late stage colorectal cancer patients. ...

Medarex says FDA approves testing of cancer drug 12:52 PM 1/28/2009
Forbes - NY,USA
Medarex Inc received approval to start clinical testing of a cancer drug candidate MDX-1203. MDX-1203 contains an antibody that targets the CD70 protein found in leukemia, lymphoma, renal cell carcinomas. ...

Roche files cancer drug MabThera for CLL leukaemia 6:55 AM 1/28/2009
Reuters - USA
Roche Holding AG filed top-selling cancer drug MabThera in the European Union for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL). CLL is the most common form of adult leukemia. ...

Novacea Stockholders Approve Merger With Transcept 12:50 PM 1/27/2009
CNNMoney.com - USA
Novacea, Inc will complete a merger with Transcept Pharmaceuticals, Inc. ...

Bristol-Myers Swings To 4Q Profit;Plavix, Abilify Sales Grow 7:27 AM 1/27/2009P
CNNMoney.com - USA
Bristol-Myers Squibb Co reversed last year's loss in the fourth quarter. The drug maker reported solid sales of anticlotting agent Plavix and psychiatric drug Abilify. It expects to complete its initial public offering of the Mead Johnson nutrition unit in the first half of 2009. ...

US FDA seeks more data on Sanofi, Bristol's Plavix 2:27 PM 1/26/2009
Reuters - USA
The US FDA is reviewing the effectiveness of the widely used blood thinner Plavix made by Sanofi-Aventis and Bristol-Myers Squibb Co. The companies will conduct studies on genetics and drug interactions. ...

KV Pharmaceutical to recall most products 12:17 PM 1/26/2009
Forbes - NY,USA
Shares of KV Pharmaceutical plummeted after the company said it would recall most of its products. It halted manufacturing and shipping operations. ...

GeoPharma gets $2.5 million for cancer business 7:52 AM 1/26/2009
Bizjournals.com - Charlotte,NC,USA
GeoPharma retains 40 percent ownership. The transaction with Trident eases GeoPharma’s burden funding its ovarian cancer business. ...

Merck KGaA Says 4 Cancer Cases Occurred in Oral MS Drug Study 6:52 AM 1/26/2009
Bloomberg - USA
Merck KGaA is seeking to be first with an oral drug for multiple sclerosis. Four patients were diagnosed with cancer during a trial of the cladribine pill. An independent monitor is aware of the cases but doesn’t consider them a safety concern. ...

<- Day Earlier | Today's News